Regulus Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 11, 2022 at 04:10 pm
Regulus Therapeutics Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 7.26 million compared to USD 6.03 million a year ago. Basic loss per share from continuing operations was USD 0.5 compared to USD 0.78 a year ago.
For the six months, net loss was USD 13.98 million compared to USD 12.05 million a year ago. Basic loss per share from continuing operations was USD 0.96 compared to USD 1.62 a year ago.